October 17, 2024
Congrats to Jake Heggestad, PhD, David Kinnamon, PhD, and Cassio Fontes, PhD, for founding their new company Simplus Diagnostics (SimplusDx)! SimplusDx is the culmination of over a decade of research and development into the D4 platform—an ultrasensitive immunoassay specifically designed for point-of-care testing. SimplusDx aims to democratize access to clinical-grade diagnostics in decentralized settings including outpatient clinics, pharmacies, and at-home. The company's cost-effective, easy-to-use test cartridges and handheld analyzer require just a single drop of blood, enabling a range of applications including therapeutic drug monitoring, chronic disease management, acute disease screening, and more.